Stem Cell Therapy of Parkinson’s Disease

Affecting close to one million Americans, Parkinson’s disease is thought to result from loss of dopamine-generating cells in the midbrain. Because there is no known cure, treatments currently focus on the management of symptoms. At Gulf Coast Stem Cell & Regenerative Medicine Center, we are committed to providing treatments that we believe will mitigate the degenerative effects of this disease. Patients seeking effective stem cell therapy of Parkinson’s disease may benefit from our procedures using mesenchymal stem cells.

Stem Cell Therapy of Parkinson’s Disease

GCSCRMC has developed a specific deployment protocol that takes advantage of the potential regenerative properties of Stromal Vascular Fraction (SVF), which is the end product of the procedure, starting with fat harvest through a mini-liposuction. This SVF is rich in both mesenchymal stem cells, growth factors, and cytokines that appear to go to work within hours of deployment in some patients. GCSCRMC takes special measures to optimize transport of SVF across the blood-brain barrier to improve central nervous system uptake, and the entire cellular surgical procedure takes approximately three hours.

Parkinson’s Disease and Gulf Coast Stem Cell & Regenerative Medicine Center

From our Ocean Springs location, Gulf Coast Stem Cell & Regenerative Medicine Center serves patients throughout the region, the rest of the United States and Canada, and indeed abroad. We take special pride in offering our patients the latest advances in protocols in order to help them achieve their personal health goals, providing compassionate and individualized care plans for our Parkinson’s patients. Should you have any questions about stem cell therapy of Parkinson’s disease, our staff would be happy to address your concerns. Please fill out the GCSCRMC Confidential Candidate Application or contact us for more information.